pharmaceutical-investing Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
Kobo Resources Extends Gold Mineralisation at Depth and Further Defines the Contact Zone Fault Target